wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36916468-019C1123-54C5-479B-A3A1-250BA58318A7
Q36916468-019C1123-54C5-479B-A3A1-250BA58318A7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36916468-019C1123-54C5-479B-A3A1-250BA58318A7
Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells
P2860
Q36916468-019C1123-54C5-479B-A3A1-250BA58318A7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36916468-019C1123-54C5-479B-A3A1-250BA58318A7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f874fa4b08a7fcd3185fe98b7940ecd0ca926799
P2860
Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma.